14-20447274-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM5PP5_Very_Strong
The NM_017807.4(OSGEP):c.974G>A(p.Arg325Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R325W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_017807.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251478Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135916
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461808Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727216
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74318
ClinVar
Submissions by phenotype
Galloway-Mowat syndrome 3 Pathogenic:3
- -
Variant summary: OSGEP c.974G>A (p.Arg325Gln) results in a conservative amino acid change located in the Gcp-like domain (IPR000905) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251478 control chromosomes. c.974G>A has been reported in the literature in both homozygous and compound heterozygous individuals affected with Galloway-Mowat Syndrome 3 (e.g., Braun_2017, Edvardson_2017), and the variant was shown to segregate with disease in at least one family. These data indicate that the variant is very likely to be associated with disease. Additionally, multiple publications report experimental evidence evaluating an impact on protein function, finding that the variant results in reduced N6-threonyl-carbamoyl-adenosine levels and increased DNA-damage response signaling (e.g., Braun_2017, Edvardson_2017). The following publications have been ascertained in the context of this evaluation (PMID: 28805828, 28272532). ClinVar contains an entry for this variant (Variation ID: 444886). Based on the evidence outlined above, the variant was classified as pathogenic. -
This variant was previously reported in multiple individuals with Galloway-Mowat syndrome 3 in homozygous state or in trans with a second OSGEP variant and segregated with the disease in family [PMID: 28272532, 28805828]. Functional studies suggested that the variant has a pathogenic effect by perturbing t6A synthesis, thereby interfering with global protein production [PMID: 28272532]. -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 325 of the OSGEP protein (p.Arg325Gln). This variant is present in population databases (rs753237335, gnomAD 0.005%). This missense change has been observed in individuals with Galloway-Mowat syndrome (PMID: 28272532, 28805828, 30141175, 31481669). ClinVar contains an entry for this variant (Variation ID: 444886). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects OSGEP function (PMID: 28272532, 28805828). For these reasons, this variant has been classified as Pathogenic. -
Galloway-Mowat syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at